[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$10047share Graphic $10047share

ITOS is potentially being acquired by Concentra Biosciences for $10.047/share. The deal is expected to begin by August 1, 2025.

About $10047share

A stock ticker symbol.

Engagements: XXX #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXXXX
1-Year High: XXXXX on 2025-07-22
1-Year Low: X on 2025-07-25

Social Network X
Engagements XXX

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1-Year High: X on 2025-07-22
1-Year Low: X on 2025-07-25

Social Network X
Mentions X

Creators: X #


Creators Line Chart
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $10047share in the last XX hours which is no change from in the previous XX hours Daily Average: X
1-Year High: X on 2025-07-22
1-Year Low: X on 2025-07-25

Top topics mentioned In the posts about $10047share in the last XX hours

$475m, alternative investment, $evo, $autl, $itos, liquid, evo, $ncna, $sabs

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"๐Ÿ“ข M&A News: Sanofi to acquire UK-based Vaccine Startup Vicebio ๐Ÿ’ธ $1.15B upfront + up to $450M in milestones. ๐Ÿงช Adds early-stage RSV + hMPV combo vaccine candidate (VXB-241) and 'Molecular Clamp' tech to pipeline. โ„ Molecular Clamp enables fully liquid fridge-stable vaccinesboosting efficiency distribution and prefilled syringe use. ๐Ÿ“… Deal expected to close in Q4 2025 See image for more details ๐Ÿ‘‡"
@BiopharmIQ on X 2025-07-22 14:39:04 UTC 25.7K followers, 3544 engagements

"$ITOS ๐ŸŒ $PMN $HSDT $ZIMV $SABS $NCNA $AUTL $EVO"
@AponiaAnalytics on X 2025-07-21 15:11:49 UTC 4972 followers, XXX engagements

"$ITOS to be acquired by Concentra Biosciences for $10.047/share in cash plus a CVR tied to net cash above $475M and potential asset sales; tender offer to begin by Aug X 2025. See More Pre-market Movers ๐Ÿ‘‡ $PMN $HSDT $ZIMV $SABS $NCNA $AUTL $EVO"
@BPharmCatalyst on X 2025-07-21 12:20:13 UTC 29.9K followers, 6175 engagements